PAR paradigm biopharmaceuticals limited..

Ann: Paradigm Secures Ethics Approval for Phase 3 Trial, page-49

  1. 4,854 Posts.
    lightbulb Created with Sketch. 7534
    Yes agree with you Dungiven, Recruitment and dosing wont be linear...it will gather steam as it progresses. So it might be a little slower than the aver 'run rate' for the first few months but then will increase in terms of rates of dosing.

    I think sometime half way through next calendar year 2026 sounds about right for interim readout. It will take about 6 weeks to compile the data I'm guessing. As you stated, we will be able to figure it out a lot more accurately once we know 50% thru.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.0¢
Change
-0.010(3.33%)
Mkt cap ! $112.9M
Open High Low Value Volume
30.0¢ 30.5¢ 29.0¢ $123.6K 421.2K

Buyers (Bids)

No. Vol. Price($)
3 36097 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 101917 1
View Market Depth
Last trade - 16.10pm 23/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.